Gretchen W. McClain
Analyst · Citi Research
Thank you, Phil. Good morning, everyone, and thank you for joining the call. We appreciate your interest in Xylem. Today is a special day for us as it marks our 1-year anniversary as a separately traded public company. As we were getting ready to celebrate this week, Hurricane Sandy hit the East Coast, leaving a path of devastation behind. I'm sure many of you and your families have been affected as many of our Xylem employees have been, so please know that our thoughts are with you. I'm always reminded in the aftermath of crisis situations such as this of the importance of the work we do. In many of the areas where flooding is a huge issue, Xylem is there with our equipment and with our expertise, helping to bring things back to normal as quickly as possible. As I reflect back over the past year and on our accomplishments, I'm proud of our team and how we've come together, staying focused on our customers, advancing our strategic initiatives, all while standing up a new company and in the face of some very difficult economic headwinds. This has been a challenging year by any standard, but a satisfying one as well. The team has sharpened its execution, tightened spending and continues to drive cost reductions to navigate through these challenging times, and as a result, our business operations continue to improve even with lower-than-anticipated revenues. But our journey has just begun. We are laying the path for growth with investments to provide customers with new products, services and solutions they're looking for. We're investing to expand geographically so we can reach our entire servable market and realize our full market share potential. And we continue to expand our portfolio with our disciplined acquisition process. And today, I'll highlight our latest addition, Heartland Pump. So special thanks goes out to our 12,000, 5,000 -- 12,500 Xylem employees around the world. They're dedicated to this business and are driving Xylem forward with long-term goals in mind. Now I'd like to walk you through our third quarter results. Our team delivered another solid quarter of operating performance. Today, we're reporting third quarter revenue of $931 million, reflecting growth of 3% on a constant currency basis. Organic growth was 1% with acquisitions adding another 2%. Revenue in Europe grew modestly despite underlying market weakness. For the third quarter, organic revenue in Europe were up 1% year-over-year. Exiting the second quarter, we've highlighted our expectations that U.S. growth would moderate during the second half. In the third quarter, U.S. organic revenue declined 3%, relative to a strong prior year performance where we posted revenue growth of 20% and organic revenue growth of 9%. This was driven by slowing industrial markets and continued drought conditions. Emerging markets continue to drive growth, up 9% on a constant currency basis, driven by strength in the Asia Pacific and Latin America regions. Our continued focus on acquisitions -- attractive acquisitions is helping us drive top line growth, adding 2% during the quarter. It is important to note that in September, we celebrated our 1-year anniversary of the YSI acquisition, and as a result for the quarter, those revenues for the month of September are now included in our organic performance. We received orders of $882 million, down 5% in constant currency resulting in a book-to-bill ratio of 0.95. Under normal market conditions, we would have expected a book-to-bill ratio of approximately 1.0 for the overall business. This puts pressure on the top line, leading into what historically has been the strongest quarter of the year. When I look at the project funnel, I remain cautiously optimistic that orders will be released, that activities for capital projects will continue to increase, but the release of orders still remains much slower than anticipated. The key focus for us has been margin expansion. Despite the lower demand, we continue to reach higher levels of profitability. You may recall from our Investor Day last fall, we had set a long-term target in gross margins of greater than 40%. We've made significant progress towards this goal in 2012, including 130 basis point improvement for the third quarter compared to prior year and surpassing the 40% mark for the first time. Operating margin was 12.9%. Excluding the impact of standalone costs, operating margin was up 50 basis points. Earnings per share were $0.44. Core operations and YSI performance drove earnings up $0.02 but were offset by foreign exchange and higher operating tax rate. Overall, our operating performance was solid, particularly in light of the market dynamics around the world. Please turn to Slide 4. Let me provide you an update on the business and the progress we've made on our strategic initiatives. We continue our focus on acquiring businesses that fit with our strategic objectives for growth and make strong additions to our portfolio. During the third quarter, we announced the acquisition of MJK and we've been successfully integrating the business into our analytical instrumentation platform. We're still in the early stages but I'm very pleased with our progress. Just last Friday, we announced the acquisition of Heartland Pump, a perfect fit for Xylem as it expands the geographic reach of our dewatering platform. These acquisitions and those that we completed over the last few years have positioned us in 2 very attractive areas, mainly dewatering and analytics. Before I move on to highlight some of our latest product launches, I'd like to recognize that during the third quarter, Xylem was selected to the Dow Jones Sustainability Global Index where we were one of 340 companies selected out of 2,500 applicants and we're also included in the North America Index, an important step in a long journey to demonstrate Xylem's focus on sustainable solutions in our business and in the communities we live. We continue to make great progress in deploying innovative new product applications and services that differentiate Xylem in the marketplace. Earlier this quarter, at the West Tech Trade Conference, we launched our Sanitaire Bioloop Oxidation Ditch into the U.S. market. Globally, this is roughly a $1 billion market. Importantly, in the time of limited CapEx spend -- expenditure by the public utilities, this offering is targeted to retrofit the significant number of aging oxidation ditch treatment plants around the globe, requiring energy-efficient solutions to address needed repairs, higher affluence standards and population growth. Bioloop's extended aeration process effectively removes nitrogen and total phosphorus, but more importantly, by combining our aeration and mixing expertise with our controlled technology that Sanitaire Bioloop can deliver energy savings of more than 50%, providing us with a clear competitive advantage. I'm happy to report that this product has captured the market's attention and we received our first order from the city of Liberty, Kentucky. In Europe, we launched our energy-efficient Lowara Ecocirc, in advance of the EU new eco-design directive, which mandates certain energy efficiency standards for the region beginning on January 1, 2013. Ecocirc not only meets the 2013 standards, but also the more stringent energy efficiency standard set forth by the directives for 2015. Our year-to-date sales for this product line are up 13%. Lastly, I'd just like to quickly highlight that our Flojet business has been recognized by the Coca-Cola Company as supplier of the year. The recognition stems from all of our team has done in terms of strategic execution, product innovation and customer intimacy. We continue our journey to increase our presence in emerging markets. For example, growing industries and the need for water and wastewater infrastructure are driving year-to-date organic growth rates of 20% in the Latin America and Asia Pacific regions, respectively. We're also working on a number of areas to ensure that we achieve the growth and margin potential our businesses are capable of delivering independent of market conditions. Progress continues against our key priorities as evidenced by our growth and operating margin expansion. Through operational excellence initiatives, we are driving faster efficiencies, lowering production costs and improving on customer satisfaction. For example, continued progress improvements have significantly increased our on-time delivery at our Auburn and Dallas manufacturing sites this year. Our global sourcing supply team has increased our efforts in low-cost countries where we currently have over 100 parts under development to lower our product costs. These projects are focused on expanding and improving the quality of our emerging market supplier base for future growth in the region and globally. Finally, we recently completed a project to reduce packaging costs, and as a result, we have decreased the consumption of wood by 36 tons at our Buffalo facility. This is just one example of the many projects our teams are working daily to reduce costs and implement sustainable solutions throughout Xylem. On the front end of our business, the processes and disciplines we've implemented around pricing through our Customer Excellence programs continues to pay off. We're delivering strong price realization in our results, approximately 1.5% during the quarter, after delivering 1.7% in the first half of the year. And in order to better position us for growth in 2013, we're executing on the restructuring and realignment actions we mentioned during last quarter's call. Turning to Slide 5. Last Friday, we announced the $29 million acquisition of privately held Heartland Pump Rentals & Sales with 2011 revenues of $33 million. This acquisition is consistent with our strategy to expand our dewatering business globally, including in the United States, and provides the additional opportunities to leverage our portfolio. With 40% of revenue coming from rental equipment and services, we further enhanced our position in attractive profitable space. With our dewatering platform now over $600 million, this acquisition will benefit from scale advantages around costs and CapEx. Similar to Godwin, Heartland serves a wide range of customers including industrial, public utilities and agencies addressing disaster recovery situations. Turning to Slide 6. Before we look ahead to the fourth quarter, let's take a quick look back and review our performance on a year-to-date basis. Orders of $2.9 billion have slightly outpaced revenue of $2.8 billion. Revenue has increased 4% on a constant currency basis. Gross margin was 39.7%, up 110 basis points over the prior year. Operating margin was 12.7%, up 60 basis points versus the prior year after adjusting for standalone costs. To put this in perspective, our year-to-date operating margin of 12.7% is the same as where we ended 2011, after absorbing $26 million of standalone costs as an independent company. And finally, we reported EPS of $1.29 and generated $171 million of free cash flow. Turning to Slide 7. Looking ahead, I'm confident we're taking the appropriate actions and have the plans in place to position Xylem for growth in 2013. Because we've not seen any significant signs of turnaround in the marketplace, we've accelerated additional restructuring and realignment actions and now expect to be at the high-end of our previous range, approximately $20 million in 2012. In addition, we are focused on integrating MJK and Heartland quickly and effectively into our portfolio, while continuing to deploy capital in the disciplined and thoughtful fashion we've demonstrated thus far, an approach focused on delivering sustainable long-term returns on investments for our shareholders. So from a full year perspective, we still expect to deliver revenues of $3.8 billion, reflecting 1% organic growth, the low-end of our previous guidance. Despite volume challenges, we will deliver solid operating performance with margins in the range of 12.7% to 12.9%, and we expect EPS in the range of $1.72 to $1.79, a midpoint of $1.76, including the $0.01 dilutive impact at Heartland. Now let me turn the call over to our CFO, Mike Speetzen, to walk through the detailed results. Mike?